NM_004360.5(CDH1):c.1019C>T (p.Thr340Met) AND Hereditary cancer-predisposing syndrome

Clinical significance:Conflicting interpretations of pathogenicity, Likely benign(1);Uncertain significance(1) (Last evaluated: Mar 24, 2019)

Review status:1 star out of maximum of 4 stars

criteria provided, conflicting interpretations

Based on:
2 submissions [Details]
Record status:
current
Accession:
RCV000129966.6

Allele description [Variation Report for NM_004360.5(CDH1):c.1019C>T (p.Thr340Met)]

NM_004360.5(CDH1):c.1019C>T (p.Thr340Met)

Gene:
CDH1:cadherin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16q22.1
Genomic location:
Preferred name:
NM_004360.5(CDH1):c.1019C>T (p.Thr340Met)
HGVS:
  • NC_000016.10:g.68812145C>T
  • NG_008021.1:g.79854C>T
  • NM_001317184.2:c.1019C>T
  • NM_001317185.2:c.-597C>T
  • NM_001317186.2:c.-801C>T
  • NM_004360.5:c.1019C>TMANE SELECT
  • NP_001304113.1:p.Thr340Met
  • NP_004351.1:p.Thr340Met
  • LRG_301t1:c.1019C>T
  • LRG_301:g.79854C>T
  • NC_000016.9:g.68846048C>T
  • NM_004360.3:c.1019C>T
  • NM_004360.4:c.1019C>T
  • p.T340M
Protein change:
T340M
Links:
dbSNP: rs61747631
NCBI 1000 Genomes Browser:
rs61747631
Molecular consequence:
  • NM_001317185.2:c.-597C>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001317186.2:c.-801C>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001317184.2:c.1019C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004360.5:c.1019C>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000184790Ambry Geneticscriteria provided, single submitter
Likely benign
(Jun 19, 2018)
germlineclinical testing

Citation Link,

SCV000689428Color Health, Inccriteria provided, single submitter
Uncertain significance
(Mar 24, 2019)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot provided1not providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Ambry Genetics, SCV000184790.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

In silico models in agreement (benign);Insufficient or conflicting evidence;Other strong data supporting benign classification

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown1not providednot provided1not providednot providednot provided

From Color Health, Inc, SCV000689428.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Aug 11, 2021

Support Center